Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions

A.C. Fears, W.B. Klimstra, P. Duprex, A. Hartman, S.C. Weaver, K.C. Plante, D. Mirchandani, J.A. Plante, P.V. Aguilar, D. Fernández, A. Nalca, A. Totura, D. Dyer, B. Kearney, M. Lackemeyer, J.K. Bohannon, R. Johnson, R.F. Garry, D.S. Reed, View ORCID ProfileC.J. Roy
doi: https://doi.org/10.1101/2020.04.13.20063784
A.C. Fears
1Tulane School of Medicine, Tulane National Primate Research Center, New Orleans, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W.B. Klimstra
2Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Duprex
2Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Hartman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.C. Weaver
3World Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity, and Department of Pathology and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K.C. Plante
3World Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity, and Department of Pathology and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Mirchandani
3World Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity, and Department of Pathology and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.A. Plante
3World Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity, and Department of Pathology and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P.V. Aguilar
3World Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity, and Department of Pathology and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Fernández
3World Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity, and Department of Pathology and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Nalca
4U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Totura
4U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Dyer
4U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Kearney
4U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Lackemeyer
5National Institutes of Health, National Institute of Allergy and Infectious Diseases, Integrated Research Facility, Fort Detrick, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.K. Bohannon
5National Institutes of Health, National Institute of Allergy and Infectious Diseases, Integrated Research Facility, Fort Detrick, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Johnson
5National Institutes of Health, National Institute of Allergy and Infectious Diseases, Integrated Research Facility, Fort Detrick, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R.F. Garry
1Tulane School of Medicine, Tulane National Primate Research Center, New Orleans, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.S. Reed
2Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C.J. Roy
1Tulane School of Medicine, Tulane National Primate Research Center, New Orleans, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C.J. Roy
  • For correspondence: croy@tulane.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The emergent coronavirus, designated severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a zoonotic pathogen that has demonstrated remarkable transmissibility in the human population and is the etiological agent of a current global pandemic called COVID-191. We measured the dynamic (short-term) aerosol efficiencies of SARS-CoV-2 and compared the efficiencies with two other emerging coronaviruses, SARS-CoV (emerged in 2002) and Middle Eastern respiratory syndrome CoV (MERS-CoV; emerged starting in 2012). We also quantified the long-term persistence of SARS-CoV-2 and its ability to maintain infectivity when suspended in aerosols for up to 16 hours.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and the the Office of the Chancellor at the University of Pittsburgh. Work performed at Tulane National Primate Research Center (CJR, ACF) was supported in part by the National Institutes of Health grant P51OD011104. RFG was supported by the National Institutes of Health grant number U19AI135995. UTMB work was supported by NIH grant R24AI120942. The Defense Health Program provided the funding for SARS-CoV-2 work in USAMRIID. The work at NIH-IRF was funded in part through the NIAID, Division of Intramural Research and Division of Clinical Research, Battelle Memorial Institute’s prime contract with NIAID under HHSN272200700016I and in whole or in part with Federal funds from the NIAID, NIH, DHHS, HHSN272201800013C. JKB performed this work as an employee of Battelle Memorial Institute. MGL performed this work as an employee of Lovelace Respiratory Research Institute and Laulima Government Solutions, LLC.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data can be made available for review upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions
A.C. Fears, W.B. Klimstra, P. Duprex, A. Hartman, S.C. Weaver, K.C. Plante, D. Mirchandani, J.A. Plante, P.V. Aguilar, D. Fernández, A. Nalca, A. Totura, D. Dyer, B. Kearney, M. Lackemeyer, J.K. Bohannon, R. Johnson, R.F. Garry, D.S. Reed, C.J. Roy
medRxiv 2020.04.13.20063784; doi: https://doi.org/10.1101/2020.04.13.20063784
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions
A.C. Fears, W.B. Klimstra, P. Duprex, A. Hartman, S.C. Weaver, K.C. Plante, D. Mirchandani, J.A. Plante, P.V. Aguilar, D. Fernández, A. Nalca, A. Totura, D. Dyer, B. Kearney, M. Lackemeyer, J.K. Bohannon, R. Johnson, R.F. Garry, D.S. Reed, C.J. Roy
medRxiv 2020.04.13.20063784; doi: https://doi.org/10.1101/2020.04.13.20063784

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (196)
  • Anesthesia (54)
  • Cardiovascular Medicine (489)
  • Dentistry and Oral Medicine (89)
  • Dermatology (56)
  • Emergency Medicine (168)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
  • Epidemiology (5677)
  • Forensic Medicine (3)
  • Gastroenterology (215)
  • Genetic and Genomic Medicine (863)
  • Geriatric Medicine (88)
  • Health Economics (230)
  • Health Informatics (761)
  • Health Policy (390)
  • Health Systems and Quality Improvement (251)
  • Hematology (105)
  • HIV/AIDS (182)
  • Infectious Diseases (except HIV/AIDS) (6471)
  • Intensive Care and Critical Care Medicine (390)
  • Medical Education (117)
  • Medical Ethics (28)
  • Nephrology (91)
  • Neurology (847)
  • Nursing (44)
  • Nutrition (141)
  • Obstetrics and Gynecology (162)
  • Occupational and Environmental Health (258)
  • Oncology (514)
  • Ophthalmology (163)
  • Orthopedics (44)
  • Otolaryngology (105)
  • Pain Medicine (48)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (250)
  • Pharmacology and Therapeutics (146)
  • Primary Care Research (114)
  • Psychiatry and Clinical Psychology (965)
  • Public and Global Health (2226)
  • Radiology and Imaging (377)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (312)
  • Rheumatology (109)
  • Sexual and Reproductive Health (80)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)